Vimarsana
Biggest News Aggregation in the World

Page 3 - Dose One News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose One. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose One Today - Breaking & Trending Today

Walk-in vaccine clinics in Nenagh today and over the weekend - Vimarsana News

Walk-in vaccine clinics in Nenagh today and over the weekend

The HSE will be operating a series of walk-in vaccine clinics in Nenagh this weekend. There are separate clinics for boosters (people aged 60-69 years), doses o...

BBCNEWS BBC News November 29, 2021 15:19:00 - Vimarsana News

BBCNEWS BBC News November 29, 2021 15:19:00

Pfizer—biontech vaccine, 12 weeks after their— pfizer—biontech vaccine, 12 weeks after their first dose. this is the same _ after their first dose. this is the same schedule as a16—17 —year—olds at the _ same schedule as a16—17 —year—olds at the moment. we are —— for 16 and 17 euros _ at the moment. we are —— for 16 and 17 euros we — at the moment. we are —— for 16 and 17 euros. we are closely watching emerging — 17 euros. we are closely watching emerging data on omicron and if there _ emerging data on omicron and if there is— emerging data on omicron and if...

'Extremely promising findings': Discovery releases... - Vimarsana News

'Extremely promising findings': Discovery releases...

An analysis of the medical aid data of more than a million Discovery Health clients has shown that the two-dose Pfizer vaccine was working extremely well at protecting against hospital admission and death, said the company’s CEO. An analysis of the medical aid data of more than a million Disc...

CNN Early Start With Christine Romans and Laura Jarrett October 8, 2021 09:23:00 - Vimarsana News

CNN Early Start With Christine Romans and Laura Jarrett October 8, 2021 09:23:00

When we looked at last year when pfizer asked for ua, the cdc gave the green light five days after they met and said it was authorized. let's look at pfizer's data. pfizer has a clinical trial with 200 participants ages 5 to 11 those children were given the dose one-third the size given to adults, and pfizer says that the vaccine was safe and generated a robust antibody response. but the fda wants to know is the children who got the vaccine in the clinical trial, were they less likely to get sick with covid later on. in the clinical trial half the children got the vaccine, half the children go...

KNTV NBC Nightly News With Lester Holt October 8, 2021 01:32:00 - Vimarsana News

KNTV NBC Nightly News With Lester Holt October 8, 2021 01:32:00

Stephanie gosk has the latest >> reporter: just in time for holiday travel that's when nearly 30 million children between the ages of 5 and 11 could become eligible for the pfizer vaccine today the company officially asking the fda for an emergency use authorization. >> i think that is amazing. i have been waiting for that for a long, long, long time >> reporter: according to pfizer, a dose one-third the size of that given to adults is both safe and effective in young children. >> i do think it makes a difference in reducing sick days, missing school, potential for hospitalizations and other c...